← Back to headlines
Telix Pharmaceuticals Reports Q1 Results and Reaffirms FY26 Outlook
Telix Pharmaceuticals announced its first-quarter financial results, confirming its previously stated outlook for fiscal year 2026.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
